Nuveen Dow 30SM Dynamic Overwrite Fund Overview

Nuveen Dow 30SM Dynamic Overwrite Fund Cost of Revenue

Cost of Revenue analysis for DIAX.

Quarterly Cost of Revenue

$2.65M

↓ 1.29% YoY

As of Dec 31, 2025

Annual Cost of Revenue (TTM)

$7.91M

↑ 55.79% YoY

Trailing 12 months ending Dec 31, 2025

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin